MRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approach

Computational Imaging Research Lab, Department of Biomedical Imaging and Image - guided Therapy, Medical University of Vienna, Austria . Abstract (2 50 words) Background We aimed to quantify hepatic vessel volumes across chronic liver disease stages and healthy controls using deep learning - based magnetic resonance imaging ( MRI) analysis, and assess correlations with biomarkers for liver (dys)function and fibrosis/portal hypertension. Methods We assessed retrospectively healthy controls, non - advanced and advanced chronic liver disease (ACLD) patients using a 3D U - Net model for hepatic vessel segmentation on portal venous phase gadoxetic acid - enhanced 3 - T MRI. Total (TVVR), hepatic (HVVR), and intrahepatic portal vein - to - volume ratios (PVVR) were compared between groups and c orrelat ed with: a lbumin - b ilirubin [ ALBI ] and "m odel for e nd - s tage l iver d isease - s odium " [ MELD - Na ] s core) and fibrosis/portal hypertension (Fibrosis - 4 [ FIB - 4 ] Score, liver stiffness measurement [ LSM ], hepatic venous pressure gradient [ HVPG ], platelet count [ PLT ], and spleen volume. Results We included 197 subjects, aged 54.9 13.8 years (mean standard deviation), 111 males ( 56 .3 TVVR and HVVR were highest in controls (3.9; 2.1), intermediate in non - ACLD (2.8; 1.7), and lowest in ACLD patients (2.3; 1.0) ( p 0. 001) . PVVR was reduced in both non - ACLD and ACLD patients (both 1.2) compared to controls (1.7) ( p 0. 001), but showed no difference between CLD groups ( p = 0.999) . TVVR and PVVR showed similar but weaker correlations. Conclusion s Deep learning - based hepatic vessel volumetry demonstrate d differences between healthy liver and chronic liver disease stages and shows correlations with established markers of disease severity. Relevance s tatement Hepatic vessel volumetry demonstrates differences between healthy liver and chronic liver disease stages, potentially serving as a non - invasive imaging biomarker.